Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

Beta BlockersAtenolol25 mg PO Q24HAdminister Post HD session

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
266856-715-356-161.142.675 (low flux)


  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL:
  • Flouvat B, Decourt S, Aubert P, et al. Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis. British journal of clinical pharmacology. 1980;9(4):379-85.
  • Inrig JK. Antihypertensive agents in hemodialysis patients: a current perspective. Seminars in dialysis. 2010;23(3):290-7.